Justin Chakma

Insider Reports History

Entity
Individual
Location
C/O Ars Pharmaceuticals, Inc., 11682 El Camino Real, Suite 120, San Diego, CA
Signature
/s/ Kathleen Scott, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Justin Chakma:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ARS Pharmaceuticals, Inc. Chief Business Officer Stock option (right to buy) 350K Jan 2, 2024 Direct

Insider Reports Filed by Justin Chakma

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SPRY ARS Pharmaceuticals, Inc. Jan 2, 2024 1 $0 4 Jan 4, 2024 Chief Business Officer
SPRY ARS Pharmaceuticals, Inc. Jan 3, 2023 1 $0 4 Jan 5, 2023 Chief Business Officer
SPRY ARS Pharmaceuticals, Inc. Nov 8, 2022 5 $0 4 Nov 10, 2022 Chief Business Officer
SPRY ARS Pharmaceuticals, Inc. Nov 8, 2022 0 $0 3 Nov 10, 2022 Chief Business Officer